SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-17-285471
Filing Date
2017-09-15
Accepted
2017-09-14 21:02:35
Documents
2
Group Members
SOFTBANK VISION FUND L.P.SVF GP (JERSEY) LTDSVF HOLDINGS (UK) LLP

Document Format Files

Seq Description Document Type Size
1 SC 13D d431387dsc13d.htm SC 13D 86899
2 EXHIBIT 1 d431387dex991.htm EX-99.1 9251
  Complete submission text file 0001193125-17-285471.txt   97882
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Subject) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-88883 | Film No.: 171086700
SIC: 2834 Pharmaceutical Preparations

Mailing Address 69 GROSVENOR STREET LONDON X0 W1K3JP
Business Address 69 GROSVENOR STREET LONDON X0 W1K3JP 6508435214
SVF Investments (UK) Ltd (Filed by) CIK: 0001716729 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D